• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ALINITY I HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ALINITY I HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 08P08-77
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/09/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.(b)(6).This report is being filed on an international product, list number 08p08, that has a similar product distributed in the us, list number 04p53.
 
Event Description
The customer observed a (b)(6) alinity i hbsag result for one patient.The following data was provided ((b)(6)): sample id (b)(6) initial result, on (b)(6)2021, was 1.92, repeat, on (b)(6) 2021, was 0.00 iu/ml.The patients samples before (b)(6) 2021 were (b)(6).Additional laboratory testing from (b)(6) 2021 was provided (no units of measure were provided): (b)(6) was (b)(6), (b)(6) was (b)(6), (b)(6) was (b)(6), (b)(6) was (b)(6).The patient had a pre-scheduled gastroscopy procedure done on (b)(6) 2021 with equipment used for patients with (b)(6) testing because of the (b)(6) hbsag result.There was no harm to the patient and the patient did not receive any treatment based on the (b)(6) alinity i hbsag result.
 
Manufacturer Narrative
Health effect impact code: f26, component code: g01003.D8.Was this device serviced by a third party? no.The complaint investigation for a false initial reactive alinity i hbsag result included a search for similar complaints, review of complaint text, trending data, labeling, and device history records.Return testing was not completed as returns were not available.Review of trending reports for the alinity i hbsag reagent did not identify any related trends.Historical performance in the field of reagent lots using worldwide data through abbottlink was evaluated.The patient median result for the lot are comparable with all other lots in the field and confirms no systemic issue for the product lot.Manufacturing documentation for the likely cause lot was reviewed and did not identify any issues.Labeling was reviewed and found to adequately address the issue under review.In this case, on (b)(6) 2021, a patient was tested for hbsag with a reactive result of 1.92 s/co.The patient was then assigned to the hepatitis b group for gastroscopic testing.On (b)(6) 2021, the patient was again tested for hbsag with a non-reactive result of 0.00 s/co.No repeat testing was performed as required per product labeling instructions for the initial reactive hbsag result.Based on the information provided and abbott diagnostics¿ complaint investigation, alinity i hbsag, lot number 16422fn01, is performing as intended, no systemic issue or deficiency was identified.Section d3 suspect medical device was updated including the phone number, email, and fax number.Section g1 all manufacturers was updated including the mfg site email and mfg site fax number.
 
Manufacturer Narrative
This follow up is submitted to populate fields d8 and/or h6 with data that had previously been provided in field.H10.There is no change to the content of the data.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HBSAG REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
MDR Report Key11244966
MDR Text Key252963857
Report Number3008344661-2021-00029
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 05/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/28/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/18/2021
Device Catalogue Number08P08-77
Device Lot Number16422FN01
Was Device Available for Evaluation? No
Date Manufacturer Received05/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI04272; ALNTY I PROCESSING MODU, 03R65-01, AI04272; ALNTY I PROCESSING MODU, 03R65-01, AI04272
Patient Outcome(s) Other;
-
-